BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 6135144)

  • 1. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
    Cox BM; Chavkin C
    Mol Pharmacol; 1983 Jan; 23(1):36-43. PubMed ID: 6135144
    [No Abstract]   [Full Text] [Related]  

  • 2. Receptor preference of dynorphin A fragments in the mouse vas deferens determined by different techniques.
    Schulz R; Wüster M; Herz A
    J Pharmacol Exp Ther; 1984 Jul; 230(1):200-4. PubMed ID: 6146706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid receptor selectivity of dynorphin gene products.
    James IF; Fischli W; Goldstein A
    J Pharmacol Exp Ther; 1984 Jan; 228(1):88-93. PubMed ID: 6141278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1984 Sep; 104(1-2):101-4. PubMed ID: 6094203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the action of putative endogenous kappa-agonists, leumorphin and rimorphin in vitro.
    Suda M; Nakao K; Yoshimasa T; Ikeda Y; Sakamoto M; Yanaihara C; Yanaihara N; Numa S; Imura H
    Life Sci; 1983; 33 Suppl 1():275-8. PubMed ID: 6319876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.
    Oka T; Negishi K; Suda M; Sawa A; Fujino M; Wakimasu M
    Eur J Pharmacol; 1982 Jan; 77(2-3):137-41. PubMed ID: 6277659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid peptides derived from pre-proenkephalin B sequence: biological evaluation in guinea pig ileum and mouse vas deferens.
    Sánchez-Blázquez P; Garzón J; Lee NM
    Proc West Pharmacol Soc; 1983; 26():85-8. PubMed ID: 6688470
    [No Abstract]   [Full Text] [Related]  

  • 8. Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues.
    James MK; Feldman PL; Schuster SV; Bilotta JM; Brackeen MF; Leighton HJ
    J Pharmacol Exp Ther; 1991 Nov; 259(2):712-8. PubMed ID: 1658308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum.
    Yoshimura K; Huidobro-Toro JP; Lee NM; Löh HH; Way EL
    J Pharmacol Exp Ther; 1982 Jul; 222(1):71-9. PubMed ID: 6123594
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of structurally different (Leu5) enkephalinamides on electrically-evoked contractions of guinea pig ileum.
    Radomirov R; Petkov VD; Venkova K
    Biomed Biochim Acta; 1987; 46(5):381-5. PubMed ID: 2822036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of mu- and delta-selective opioid agonists in the guinea pig ileum preparation: differentiation into peptide and nonpeptide classes with beta-funaltrexamine.
    Ward SJ; LoPresti D; James DW
    J Pharmacol Exp Ther; 1986 Aug; 238(2):625-31. PubMed ID: 3016244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid profiles of Cys2-containing enkephalin analogues.
    Pencheva N; Milanov P; Vezenkov L; Pajpanova T; Naydenova E
    Eur J Pharmacol; 2004 Sep; 498(1-3):249-56. PubMed ID: 15364002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid receptors in the mouse ileum.
    Smith CF; Waldron C; Brook NA
    Arch Int Pharmacodyn Ther; 1988; 291():122-31. PubMed ID: 2835021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible blockade of the kappa-receptor by a newly synthesized dynorphin derivative containing a 3-nitro-2-pyridinesulfenyl group.
    Koike K; Takayanagi I; Hirakura Y; Matsueda R
    Arch Int Pharmacodyn Ther; 1991; 313():33-46. PubMed ID: 1687773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional opiate receptor in mouse vas deferens: evidence for a complex interaction.
    Sánchez-Blázquez P; Garzón J; Lee NM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):706-11. PubMed ID: 6310079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine.
    Hayes AG; Sheehan MJ; Tyers MB
    Br J Pharmacol; 1985 Dec; 86(4):899-904. PubMed ID: 3000501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proglumide exhibits delta opioid agonist properties.
    Rezvani A; Stokes KB; Rhoads DL; Way EL
    Alcohol Drug Res; 1987; 7(3):135-46. PubMed ID: 3030338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative studies of 2 methods for the quantitative measurement of endorphins in the cerebrospinal fluid. The mouse vas deferens and opiate-receptor binding].
    Laorden ML; Olaso MJ; Miralles F; Puig MM
    Arch Farmacol Toxicol; 1983 Aug; 9(2):165-70. PubMed ID: 6318675
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro evaluation of a casomorphin related pentapeptide, a competitive mu opioid receptor antagonist.
    Davis P; Tourwe D; Delaet N; Kramer TH; Burks TF
    Proc West Pharmacol Soc; 1991; 34():429-32. PubMed ID: 1664962
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cys(O2NH2)2]enkephalin analogues and dalargin: selectivity for delta-opioid receptors.
    Pencheva N; Bocheva A; Dimitrov E; Ivancheva C; Radomirov R
    Eur J Pharmacol; 1996 May; 304(1-3):99-108. PubMed ID: 8813590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.